State Street’s Precision BioSciences DTIL Stock Holding History

State Street’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.36M	Buy	427,325 +354,383	+486%	+$2.49M	﹤0.01%	3171
2026 Q1	$401K	Buy	72,942 +13,900	+24%	+$64.1K	﹤0.01%	3712
2025 Q4	$246K	Buy	59,042 +20,900	+55%	+$119K	﹤0.01%	3852
2025 Q3	$211K	Buy	38,142 +11,900	+45%	+$57K	﹤0.01%	3900
2025 Q2	$110K	Buy	26,242 +4,200	+19%	+$20.7K	﹤0.01%	3960
2025 Q1	$105K	Hold	22,042	–	–	﹤0.01%	3969
2024 Q4	$84K	Buy	22,042 +10,800	+96%	+$78.9K	﹤0.01%	4026
2024 Q3	$101K	Hold	11,242	–	–	﹤0.01%	3974
2024 Q2	$109K	Buy	+11,242	New	+$132K	﹤0.01%	3987
2024 Q1	–	Sell	-8,145	Closed	-$89.2K	–	4376
2023 Q4	$89.2K	Hold	8,145	–	–	﹤0.01%	4074
2023 Q3	$83.4K	Hold	8,145	–	–	﹤0.01%	4153
2023 Q2	$129K	Hold	8,145	–	–	﹤0.01%	4144
2023 Q1	$184K	Buy	8,145 +750	+10%	+$24.7K	﹤0.01%	4105
2022 Q4	$264K	Buy	7,395 +1,857	+34%	+$73.4K	﹤0.01%	4005
2022 Q3	$216K	Hold	5,538	–	–	﹤0.01%	4104
2022 Q2	$266K	Sell	5,538 -36,322	-87%	-$2.13M	﹤0.01%	4084
2022 Q1	$3.87M	Sell	41,860 -52,097	-55%	-$7.08M	﹤0.01%	3305
2021 Q4	$20.9M	Buy	93,957 +9,502	+11%	+$2.65M	﹤0.01%	2451
2021 Q3	$29.2M	Sell	84,455 -8,427	-9%	-$2.86M	﹤0.01%	2200
2021 Q2	$34.9M	Sell	92,882 -78,743	-46%	-$23.7M	﹤0.01%	2115
2021 Q1	$53.3M	Buy	171,625 +85,428	+99%	+$29.9M	﹤0.01%	1703
2020 Q4	$21.6M	Buy	86,197 +60,452	+235%	+$14.8M	﹤0.01%	2202
2020 Q3	$4.76M	Buy	25,745 +335	+1%	+$66.6K	﹤0.01%	2814
2020 Q2	$6.35M	Buy	25,410 +5,335	+27%	+$1.17M	﹤0.01%	2643
2020 Q1	$3.63M	Buy	20,075 +1,587	+9%	+$415K	﹤0.01%	2783
2019 Q4	$7.7M	Buy	18,488 +13,737	+289%	+$4.32M	﹤0.01%	2651
2019 Q3	$1.2M	Buy	4,751 +79	+2%	+$25.7K	﹤0.01%	3367
2019 Q2	$1.34M	Buy	+4,672	New	+$1.88M	﹤0.01%	3368

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street's DTIL Position: Q2 2026 in Review

State Street increased its Precision BioSciences (DTIL) stake by 486% in Q2 2026, buying an estimated $2.49M and bringing the position to 427,325 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

State Street first reported a position in DTIL in Q2 2019 and has held it in 28 quarters since. The position peaked at $53.3M in Q1 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

State Street held 427,325 shares of Precision BioSciences worth $3.36M as of Q2 2026.
State Street bought 354,383 Precision BioSciences shares in Q2 2026, an estimated $2.49M.
Precision BioSciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3171 holding.
State Street first reported a position in Precision BioSciences in Q2 2019 and has held it in 28 quarters since.
State Street's Precision BioSciences position peaked at $53.3M in Q1 2021.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.